Cargando…
Propofol and survival: an updated meta-analysis of randomized clinical trials
BACKGROUND: Propofol is one of the most widely used hypnotic agents in the world. Nonetheless, propofol might have detrimental effects on clinically relevant outcomes, possibly due to inhibition of other interventions' organ protective properties. We performed a systematic review and meta-analy...
Autores principales: | Kotani, Yuki, Pruna, Alessandro, Turi, Stefano, Borghi, Giovanni, Lee, Todd C., Zangrillo, Alberto, Landoni, Giovanni, Pasin, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099692/ https://www.ncbi.nlm.nih.gov/pubmed/37046269 http://dx.doi.org/10.1186/s13054-023-04431-8 |
Ejemplares similares
-
Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply
por: Kotani, Yuki, et al.
Publicado: (2023) -
Thiopental is better than propofol for electroconvulsive therapy
por: Nuzzi, Massimiliano, et al.
Publicado: (2017) -
Authors’ reply to Hansel’s letter to the editor
por: Kotani, Yuki, et al.
Publicado: (2023) -
Authors’ reply to the comment from Glass et al.
por: Kotani, Yuki, et al.
Publicado: (2023) -
Positive single-center randomized trials and subsequent multicenter randomized trials in critically ill patients: a systematic review
por: Kotani, Yuki, et al.
Publicado: (2023)